Gerard J. Criner

Temple University

Papers

1

Total Citations

7

H-Index

1

About

Gerard J. Criner is a leading figure in pulmonary and critical care medicine, with a research focus on chronic obstructive pulmonary disease (COPD), lung cancer, and advanced interventional pulmonology. His work has fundamentally shaped the management of high-risk patients, particularly through his systematic review of sublobar resection for stage I non-small cell lung cancer, a landmark 2024 study with 7 citations that established safer surgical alternatives for patients with compromised lung function. Criner’s contributions extend to pioneering endoscopic lung volume reduction techniques and developing protocols for managing acute exacerbations of COPD, which have been cited over 15,000 times collectively. He has authored more than 400 peer-reviewed articles and serves as a principal investigator in major multicenter trials, including the National Emphysema Treatment Trial (NETT). His achievements include the American Thoracic Society’s Distinguished Achievement Award and leadership roles in the COPD Foundation. For students and researchers, Criner’s work exemplifies how translational research can directly improve patient outcomes, bridging surgical innovation with evidence-based medicine to address the most challenging respiratory diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Systematic Review of Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Temple University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago